Novel dispiro[pyrazolidine-4,3'-pyrrolidine-2',3"-indoline]-2",3,5-triones 5a-j were obtained regioselectively by 1,3-dipolar cycloaddition reaction of 4-arylidene-1-phenylpyrazolidine-3,5-diones 2a-e as dipolarophiles with non-stabilized azomethine ylides, generated in situ via decarboxylative condensation of isatins 3a,b and sarcosine 4 in dry ethanol. The prepared compounds were screened for their anti-inflammatory activity "at a dose of 10 mg/kg body weight", especially 5d, 5f, 5h, and 5j which reveal remarkable activities relative to indomethacin which was used as a reference standard in this study.
Introduction
Cycloadditions are an important group of reactions in organic synthesis. 1 The azomethine ylide represents one of the most reactive and versatile classes of 1,3-dipoles and is trapped readily by a range of dipolarophiles, either inter or intramolecularly, forming substituted pyrrolidines. 2 Spiropyrrolidinyl-oxoindole represents the main alkaloid skeleton of naturally occurring substances such as spirotryprostatine A and spirotryprostatine B which were found to be inhibitors of mammalian cell cycle at G2/M phase, from the secondary metabolites of Aspergillus fumigatus (Figure 1 ). [3] [4] [5] N-Arylpyrazoles are a very interesting class of heterocyclic compounds that have remarkable pharmacological activities in areas such as antibacterialantifungal, 6 hypoglycemic, 7 tumor necrosis inhibition, 8 anti-thrombo-embolic disorders, as antiangiogenic-, 9 and anti-inflammatory effects. 10, 11 In the present work, it is intended to utilize a natural product isatin scaffold for formation of non-stabilized azomethine ylides following the previously described and successful methods, [12] [13] [14] [15] through decarboxylative condensation with α-amino acids and trapping the generated reactive intermediate via 1,3-dipolar cycloaddition reaction with the exocyclic olefinic linkage derived from 1-phenylpyrazolidine-3,5-dione. The anti-inflammatory properties of the prepared Reaction of the 4-arylidene-1-phenylpyrazolidine-3,5-diones 2a-e with non-stabilized azomethine ylides, generated in situ via decarboxylative condensation of sarcosine 4 and isatins 3a,b (Scheme 2) [12] [13] [14] [15] in refluxing ethanol afforded only one product, as indicated by TLC, in a highly regio-and stereo-selective manner (Scheme 3). This cycloaddition is regioselective with the electron-rich carbon of the dipole adding to the β-carbon of the α,β-unsaturated moiety of 2a-e, and is stereoselective, affording only one diastereomer exclusively, despite the presence of three stereo-centers in the product as found in many similar cycloaddition studies.
The regioselectivity of the product formation can be explained by considering secondary interaction of the orbitals of the carbonyl group of the dipolarophiles 2a-e with those of the azomethine ylide, as shown in (Figure 2) . 23 Accordingly, the formation of the observed regioisomers 5a-j via path A is more favorable than 6a-j due to the secondary orbital interaction (SOI) which is not possible in path B. Hence, only one set of regio-isomers 5a-j was formed. The structures of the isolated products were established to be dispiro[pyrazolidine-4,3'-pyrrolidine-2',3"-indoline]-2",3,5-triones, 5a-j, rather than the regio-isomeric form dispiro[pyrazolidine-4,4'-pyrrolidine-2',3''-indoline]-2",3,5-triones, 6a-j, based on spectroscopic (IR, 1 H-, 13 C-NMR, MS) and elemental analysis data. 1 H-NMR spectra of 5a-j reveal the presence of three triplet signal sets at δ = 3.54-3.63, 3.95-4.02 ppm (assignable for the magnetically non-equivalent pyrrolidinyl methylene protons H2C-5', coupled with each other and in turn with the vicinal methine proton HC-4') and 4.86-5.01 ppm (corresponding to the pyrrolidinyl methine proton HC-4'), excluding the formation of the other regio-isomeric form 6. If the other isomers 6a-j were formed, one would expect a singlet instead of a triplet for the pyrrolidinyl methylene and methine protons. The 13 C-NMR spectrum of 5b, as a representative example, exhibits the pyrrolidinyl spiro-carbons C-4 (C-3'), C-2' (C-3") at δ = 64.99, 76.33 ppm beside the pyrrolidinyl methine carbon (HC-4') at δ = 45.25, the pyrrolidinyl methylene carbon (H2C-5') appeared at δ = 55.06 ppm. In addition, the indolyl and pyrazolyl carbonyl carbon atoms appeared at δ = 174.67, 174.85 respectively. The mass spectrum of 5b, as a representative example, showed the M + peak at m/z = 372.35 (20 %) and the base peak at m/z = 173.92.
Along with the experimental investigation, and for further confirmation of the structures of the synthesized compounds 5a-j, we also carried out some theoretical studies on selected prepared compounds, with the help of molecular modeling software. For example, the calculated heat of formation (∆H) of 5b ( Figure 3) showed that the most stable form (with the lowest heat of formation) is 2'S, 3'R, 4'R (∆H= 68.622 kcal/mol). 
Anti-inflammatory activity
The anti-inflammatory activity of the target compounds 5a-j (at a dose of 10 mg/kg body weight) was determined in vivo by the acute carrageenan-induced paw oedema standard. 24 The antiinflammatory properties were recorded at successive time intervals 0.5, 1, 2, 3, and 4h and compared with that of indomethacin (at a dose of 10 mg/kg body weight) which was used as a reference standard. From the obtained results (Table 1) it was noticed after 1 h that many of the tested compounds exhibit considerable anti-inflammatory properties (especially 5d, 5f, 5h, and 5j) which reveal remarkable activities, with potency (percentage oedema inhibition of the tested compounds relative to percentage oedema inhibition of indomethacin) of 0.72, 0.64, 0.56, and 0.72 respectively. The structure-activity relationships based on the obtained results indicated that the type of substituents attached to N-1" and C-4' are controlling factors in developing the total pharmacological properties. The best observed anti-inflammatory property is that in which N-1'' bears a methyl group and C-4' is attached to a phenyl group substituted with an electron-donating group (methoxy) in 5j (potency 0.72). However, with an unsubstituted phenyl group, or substitution with electron-withdrawing groups (chlorine and bromine) the function was relatively decreased. It was also noticed that when N-1" is attached to a hydrogen atom, the antiinflammatory activity is increased only when C-4' is attached to a phenyl group substituted with an electron-donating hydroxyl group in 5d (potency 0.72).
Acute toxicity (LD50)
The median lethal dose (LD50) of the most active compounds 5d, 5f, 5h, and 5j was determined in mice, according to reported procedures. 25 The results showed that the tested compounds 5d, 5f, 5h, and 5j were non-toxic at doses up to 200 mg / kg. General. The time required for completion of each reaction was monitored by TLC. All melting points are uncorrected, and were measured on a Gallenkamp apparatus. The IR spectra were recorded on a Shimadzu 470 IR spectrometer (KBr) νmax /cm -1 . The 1 H-, and 13 C-NMR spectra were measured on Varian EM-200 ( 1 H, 200 MHz; 13 C, 50 MHz) spectrometer with TMS as internal standard and DMSO-d6 as solvent. Mass spectra were determined on a JEOL JMS-600 spectrometer. The molecular modeling software is MOPAC (ChemOffice ultra, version 9, 2005). Elemental analyses (C, H, N, and S) were performed on an elemental analysis system GmbH VarioEL V2.3; the results were found to be in good agreement with the calculated values. 
Anti-inflammatory activity screening
The anti-inflammatory activity screening for the prepared compounds 5a-j was determined in vivo by the acute carrageenan-induced paw oedema standard method in comparison to indomethacin as reference drug. 24 The test is based on the pedal inflammation in rat paws induced by sub-plantar injection of 0.2 mL carrageenan (0.2 %) suspension (5 % NaCMC) into the right hind paw of the rats (the tested compounds were dissolved in distilled water with sonication). Male adult albino rats (120-150 g) were divided into groups, each of four animals. The thickness of the rat paw was measured by a Vernier caliper (SMIEC, China) before and after 1 h of carrageenan injection to detect the inflammation induced by carrageenan. Test compounds at doses of 10 mg / kg (body weight) were injected i.p. to nine groups of rats. Control group received the vehicle (5 % NaCMC); while reference group received Indomethacin at 10 mg / kg (body weight). The difference between the thicknesses of the two paws was taken as a measure of oedema. The measurement was carried out at 1, 2, 3, and 4 h, after injection of the tested compounds, the reference drug, and the vehicle. The anti-inflammatory activity was expressed as percentage inhibition of oedema volume in treated animals in comparison with the control group (see Table 1 ).
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Percentage inhibition of oedema = X 100
where Vc and Vt are the volumes of oedema for the control-and drug-treated-animal groups, respectively.
Potency of the tested compounds was calculated relative to indomethacin "reference standard" treated group according to the following equation:
Percentage oedema inhibition of tested compound treated group
Percentage oedema inhibition of indomethacin treated group Potency = Determination of acute toxicity (LD50). The median lethal dose (LD50) of the most active compound 5d, 5f, 5h, and 5j was determined in mice. A group of male adult albino mice of five animals (25-30 g) was injected (i.p.) at a certain grade. The percentage of mortality was determined 72 h after injection. The computation of LD50 was processed by a graphical method.
